脳卒中の診断と治療の世界市場レポート 2025年

脳卒中の診断と治療市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）8.5％で503億7,000万米ドルに成長します。予測期間の成長は、糖尿病患者の急増、高血圧患者数の増加、脳卒中発症リスクのある患者数の増加、脳卒中予防に対する意識の高まり、脳卒中患者の発生率と有病率の増加などに起因すると考えられます。予測期間における主な動向としては、人工知能（AI）および機械学習（ml）アルゴリズムの採用増加、電力機器の進歩、継続的なヘルスケア技術の進歩、迅速かつ正確な診断ツールの開発、遠隔医療および遠隔脳卒中サービスの開発などが挙げられます。

脳卒中の有病率の上昇は、脳卒中の診断と治療市場の成長を促進すると予測されています。脳卒中は、脳の一部への血流が途絶えたり減少したりすることで脳組織から必要な酸素や栄養素が奪われ、脳細胞の損傷や死につながることで発生します。高血圧は血管を損傷し、破裂や閉塞を起こしやすくすることで脳卒中リスクを高める。効果的な脳卒中の診断と治療は極めて重要であり、迅速な診断と介入は脳障害、身体障害、死亡率を大幅に軽減することができるからです。例えば、2024年1月に米国心臓協会が発表した報告書によると、2021年の脳卒中による死亡者数は世界で744万人であり、その内訳は虚血性脳卒中が371万人、脳内出血が338万人、くも膜下出血が36万人でした。同様に、2023年1月の報告書では、脳卒中関連死708万人、うち348万人が虚血性脳卒中、325万人が脳内出血、35万人がくも膜下出血でした。その結果、脳卒中発症率の増加が脳卒中の診断と治療市場の拡大に拍車をかけています。

脳卒中の診断と治療市場の主要企業は、脳卒中の診断と治療の精度と効率を高めるために、AIベースの先進的なヘルスケアプラットフォームを開発しています。これらのAI主導型プラットフォームは、大量の患者データを分析し、パターンを特定し、診断精度、治療効率、個別化ケアを改善するための洞察を提供します。例えば、米国を拠点とするAI技術プロバイダーのRapidAIは、2023年11月にRapid Edge Cloudを立ち上げました。このハイブリッド・プラットフォームは、クラウドとオンプレミスの技術を統合し、スピード、セキュリティ、柔軟性を高める。病院やサードパーティのアプリケーションとシームレスに接続し、世界第2位の脳卒中市場である日本ではクラスIIIのShoninクリアランスを達成しています。Rapid Edge Cloudは、独自のMRベースの灌流機能により、高度な脳卒中画像診断と機械的血栓除去術の判定をサポートします。Rapid NCCT Stroke、Rapid ASPECTS、Rapid Hypodensity、Rapid Hyperdensity、Rapid SDHなど、AIを搭載した非造影CTソリューションは、初回のCT検査で脳卒中の可能性がある症例を検出するよう設計されており、意思決定と治療時間を短縮し、患者の転帰を改善します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界脳卒中の診断と治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の脳卒中の診断と治療市場：成長率分析
• 世界の脳卒中の診断と治療市場の実績：規模と成長, 2019-2024
• 世界の脳卒中の診断と治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界脳卒中の診断と治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の脳卒中の診断と治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断
• 治療薬
• 世界の脳卒中の診断と治療市場脳卒中予防戦略、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物管理
• ライフスタイルの変更
• 外科的介入
• 世界の脳卒中の診断と治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 出血性脳卒中
• 虚血性脳卒中
• 世界の脳卒中の診断と治療市場、診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像技術
• 血液検査とバイオマーカー分析
• 超音波画像診断
• 神経画像装置
• 脳卒中リスク評価ツール
• 世界の脳卒中の診断と治療市場、治療薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血栓溶解薬
• 抗血小板薬
• 抗凝固薬
• 外科的介入
• リハビリテーション機器と治療ソリューション
• 神経調節療法

第7章 地域別・国別分析

• 世界の脳卒中の診断と治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の脳卒中の診断と治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脳卒中の診断と治療市場：競合情勢
• 脳卒中の診断と治療市場：企業プロファイル
  • Johnson & Johnson Service Inc Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Siemens Healthineers AG
• Koninklijke Philips N. V.
• Stryker Corporation
• GE HealthCare Technologies Inc.
• Boston Scientific Corporation
• Terumo Corporation
• Genentech Inc.
• Nihon Kohden Corporation
• MicroPort Scientific Corporation
• Penumbra Inc.
• ASAHI INTECC CO. LTD.
• Silk Road Medical Inc.
• RapidAI
• Pharmazz Inc.
• Medfield Diagnostics AB

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 脳卒中の診断と治療市場2029：新たな機会を提供する国
• 脳卒中の診断と治療市場2029：新たな機会を提供するセグメント
• 脳卒中の診断と治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Stroke diagnostics and therapeutics encompass the methods and treatments used to detect and manage strokes. Diagnostic techniques help visualize brain damage and identify the type of stroke, while therapeutic strategies focus on medical treatments and procedures to restore blood flow, minimize brain injury, and support patient rehabilitation. The goal is to quickly diagnose strokes and provide effective treatment to reduce long-term disability and improve recovery.

The primary categories in stroke diagnostics and therapeutics are diagnostics and therapeutics. Diagnostics involve tools and methods used to identify and evaluate strokes, which are essential for determining the stroke type and selecting appropriate treatments. Therapeutic strategies include stroke prevention methods such as medication management, lifestyle changes, and surgical interventions, applicable to various stroke types, including hemorrhagic and ischemic strokes.

The stroke diagnostic and therapeutic market research report is one of a series of new reports from The Business Research Company that provides stroke diagnostic and therapeutic market statistics, including the stroke diagnostic and therapeutic industry global market size, regional shares, competitors with the stroke diagnostic and therapeutic market share, detailed stroke diagnostic and therapeutic market segments, market trends, and opportunities, and any further data you may need to thrive in the stroke diagnostic and therapeutic industry. These stroke diagnostic and therapeutic market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The stroke diagnostic and therapeutic market size has grown strongly in recent years. It will grow from $33.41 billion in 2024 to $36.36 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising government funding and programs, development in access to healthcare services, rapid urbanization, growing better healthcare facilities, and the rapid expansion of telemedicine and tele-stroke services.

The stroke diagnostic and therapeutic market size is expected to see strong growth in the next few years. It will grow to $50.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the surge in cases of diabetes, the rising number of patients with high blood pressure, increasing the number of patients at risk of developing stroke, raising awareness about stroke prevention, the increasing incidence and prevalence of stroke cases. Major trends in the forecast period include the increasing adoption of artificial intelligence (ai) and machine learning (ml) algorithms, advancement in power instruments, ongoing healthcare technology advancements, development in rapid and accurate diagnostic tools, and development in telemedicine and tele-stroke services.

The rising prevalence of stroke cases is anticipated to drive growth in the stroke diagnostic and therapeutic market. A stroke occurs when blood flow to a part of the brain is disrupted or reduced, depriving brain tissue of essential oxygen and nutrients, which can lead to brain cell damage or death. Hypertension increases stroke risk by damaging blood vessels, making them more prone to rupture or blockage. Effective stroke diagnostics and treatments are crucial, as prompt diagnosis and intervention can significantly mitigate brain damage, disability, and mortality. For example, a report by the American Heart Association in January 2024 indicated that stroke was responsible for 7.44 million deaths worldwide in 2021, including 3.71 million from ischemic stroke, 3.38 million from intracerebral hemorrhage, and 0.36 million from subarachnoid hemorrhage. Similarly, a report in January 2023 highlighted 7.08 million stroke-related deaths, with 3.48 million from ischemic stroke, 3.25 million from intracerebral hemorrhage, and 0.35 million from subarachnoid hemorrhage. Consequently, the growing incidence of stroke is fueling the expansion of the stroke diagnostic and therapeutic market.

Leading companies in the stroke diagnostic and therapeutic market are developing advanced AI-based healthcare platforms to enhance the precision and efficiency of stroke diagnosis and treatment. These AI-driven platforms analyze large volumes of patient data, identify patterns, and provide insights to improve diagnostic accuracy, treatment efficiency, and personalized care. For instance, RapidAI, a US-based AI technology provider, launched Rapid Edge Cloud in November 2023. This hybrid platform integrates cloud and on-premise technologies to boost speed, security, and flexibility. It seamlessly connects with hospital and third-party applications and has achieved Class III Shonin clearance in Japan, the world's second-largest stroke market. Rapid Edge Cloud supports advanced stroke imaging and mechanical thrombectomy determination with unique MR-based perfusion capabilities. Its AI-powered non-contrast CT solutions, including Rapid NCCT Stroke, Rapid ASPECTS, Rapid Hypodensity, Rapid Hyperdensity, and Rapid SDH, are designed to detect potential stroke cases during initial CT scans, thus reducing decision-making and treatment times and improving patient outcomes.

In April 2022, Wallaby Medical Holding, Inc., a US-based developer of neurovascular interventional products for stroke treatment, acquired Phenox GmbH for $550 million. This acquisition expands Wallaby's portfolio of neurovascular interventional products, particularly for ischemic and hemorrhagic stroke treatments. The integration of Phenox's clinically proven technologies with Wallaby's offerings will enable a more comprehensive range of solutions for healthcare providers. Phenox GmbH, based in Germany, specializes in technologies for treating neurovascular diseases such as ischemic and hemorrhagic strokes.

Major companies operating in the stroke diagnostic and therapeutic market are Johnson & Johnson Service Inc, Bayer AG, Abbott Laboratories, Medtronic plc, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Koninklijke Philips N. V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Genentech Inc., Nihon Kohden Corporation, MicroPort Scientific Corporation, Penumbra Inc., ASAHI INTECC CO. LTD., Silk Road Medical Inc., RapidAI, Pharmazz Inc., Medfield Diagnostics AB, Perfuze Limited, Qure.ai Technologies Private limited

North America was the largest region in the stroke diagnostic and therapeutic market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stroke diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the stroke diagnostic and therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stroke diagnostic and therapeutic market consists of revenues earned by entities providing services such as telemedicine consultations, emergency stroke care, endovascular therapy, patient education and support programs, follow-up and monitoring, and pharmacotherapy management. The market value includes the value of related goods sold by the service provider or included within the service offering. The stroke diagnostic and therapeutic market also includes sales of mechanical thrombectomy devices, antiplatelet drugs, anticoagulants, and blood pressure monitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stroke Diagnostic And Therapeutic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stroke diagnostic and therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stroke diagnostic and therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stroke diagnostic and therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diagnostics; Therapeutics
• 2) By Stroke Prevention Strategies: Medication Management; Lifestyle Modifications; Surgical Interventions
• 3) By Application: Hemorrhagic Stroke; Ischemic Stroke
• Subsegments:
• 1) By Diagnostics: Imaging Techniques; Blood Tests And Biomarker Analysis; Ultrasound Imaging; Neuroimaging Devices; Stroke Risk Assessment Tools
• 2) By Therapeutics: Thrombolytic Medications; Antiplatelet Agents; Anticoagulants; Surgical Interventions; Rehabilitation Devices And Therapy Solutions; Neuromodulation Therapies
• Companies Mentioned: Johnson & Johnson Service Inc; Bayer AG; Abbott Laboratories; Medtronic plc; Boehringer Ingelheim International GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stroke Diagnostic And Therapeutic Market Characteristics

3. Stroke Diagnostic And Therapeutic Market Trends And Strategies

4. Stroke Diagnostic And Therapeutic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Stroke Diagnostic And Therapeutic Growth Analysis And Strategic Analysis Framework

• 5.1. Global Stroke Diagnostic And Therapeutic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Stroke Diagnostic And Therapeutic Market Growth Rate Analysis
• 5.4. Global Stroke Diagnostic And Therapeutic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Stroke Diagnostic And Therapeutic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Stroke Diagnostic And Therapeutic Total Addressable Market (TAM)

6. Stroke Diagnostic And Therapeutic Market Segmentation

• 6.1. Global Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Therapeutics
• 6.2. Global Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication Management
• Lifestyle Modifications
• Surgical Interventions
• 6.3. Global Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemorrhagic Stroke
• Ischemic Stroke
• 6.4. Global Stroke Diagnostic And Therapeutic Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Techniques
• Blood Tests And Biomarker Analysis
• Ultrasound Imaging
• Neuroimaging Devices
• Stroke Risk Assessment Tools
• 6.5. Global Stroke Diagnostic And Therapeutic Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thrombolytic Medications
• Antiplatelet Agents
• Anticoagulants
• Surgical Interventions
• Rehabilitation Devices And Therapy Solutions
• Neuromodulation Therapies

7. Stroke Diagnostic And Therapeutic Market Regional And Country Analysis

• 7.1. Global Stroke Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Stroke Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stroke Diagnostic And Therapeutic Market

• 8.1. Asia-Pacific Stroke Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stroke Diagnostic And Therapeutic Market

• 9.1. China Stroke Diagnostic And Therapeutic Market Overview
• 9.2. China Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stroke Diagnostic And Therapeutic Market

• 10.1. India Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stroke Diagnostic And Therapeutic Market

• 11.1. Japan Stroke Diagnostic And Therapeutic Market Overview
• 11.2. Japan Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stroke Diagnostic And Therapeutic Market

• 12.1. Australia Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stroke Diagnostic And Therapeutic Market

• 13.1. Indonesia Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stroke Diagnostic And Therapeutic Market

• 14.1. South Korea Stroke Diagnostic And Therapeutic Market Overview
• 14.2. South Korea Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stroke Diagnostic And Therapeutic Market

• 15.1. Western Europe Stroke Diagnostic And Therapeutic Market Overview
• 15.2. Western Europe Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stroke Diagnostic And Therapeutic Market

• 16.1. UK Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stroke Diagnostic And Therapeutic Market

• 17.1. Germany Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stroke Diagnostic And Therapeutic Market

• 18.1. France Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stroke Diagnostic And Therapeutic Market

• 19.1. Italy Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stroke Diagnostic And Therapeutic Market

• 20.1. Spain Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stroke Diagnostic And Therapeutic Market

• 21.1. Eastern Europe Stroke Diagnostic And Therapeutic Market Overview
• 21.2. Eastern Europe Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stroke Diagnostic And Therapeutic Market

• 22.1. Russia Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stroke Diagnostic And Therapeutic Market

• 23.1. North America Stroke Diagnostic And Therapeutic Market Overview
• 23.2. North America Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stroke Diagnostic And Therapeutic Market

• 24.1. USA Stroke Diagnostic And Therapeutic Market Overview
• 24.2. USA Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stroke Diagnostic And Therapeutic Market

• 25.1. Canada Stroke Diagnostic And Therapeutic Market Overview
• 25.2. Canada Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stroke Diagnostic And Therapeutic Market

• 26.1. South America Stroke Diagnostic And Therapeutic Market Overview
• 26.2. South America Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stroke Diagnostic And Therapeutic Market

• 27.1. Brazil Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stroke Diagnostic And Therapeutic Market

• 28.1. Middle East Stroke Diagnostic And Therapeutic Market Overview
• 28.2. Middle East Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stroke Diagnostic And Therapeutic Market

• 29.1. Africa Stroke Diagnostic And Therapeutic Market Overview
• 29.2. Africa Stroke Diagnostic And Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Stroke Diagnostic And Therapeutic Market, Segmentation By Stroke Prevention Strategies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Stroke Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stroke Diagnostic And Therapeutic Market Competitive Landscape And Company Profiles

• 30.1. Stroke Diagnostic And Therapeutic Market Competitive Landscape
• 30.2. Stroke Diagnostic And Therapeutic Market Company Profiles
  • 30.2.1. Johnson & Johnson Service Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Stroke Diagnostic And Therapeutic Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers AG
• 31.2. Koninklijke Philips N. V.
• 31.3. Stryker Corporation
• 31.4. GE HealthCare Technologies Inc.
• 31.5. Boston Scientific Corporation
• 31.6. Terumo Corporation
• 31.7. Genentech Inc.
• 31.8. Nihon Kohden Corporation
• 31.9. MicroPort Scientific Corporation
• 31.10. Penumbra Inc.
• 31.11. ASAHI INTECC CO. LTD.
• 31.12. Silk Road Medical Inc.
• 31.13. RapidAI
• 31.14. Pharmazz Inc.
• 31.15. Medfield Diagnostics AB

32. Global Stroke Diagnostic And Therapeutic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stroke Diagnostic And Therapeutic Market

34. Recent Developments In The Stroke Diagnostic And Therapeutic Market

35. Stroke Diagnostic And Therapeutic Market High Potential Countries, Segments and Strategies

• 35.1 Stroke Diagnostic And Therapeutic Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Stroke Diagnostic And Therapeutic Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Stroke Diagnostic And Therapeutic Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33584_Stroke_Diagnostic_And_Therapeutic_GMR_2025